{"id":27236,"date":"2024-12-03T12:34:52","date_gmt":"2024-12-03T19:34:52","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/uncategorized\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/"},"modified":"2025-04-28T14:10:02","modified_gmt":"2025-04-28T21:10:02","slug":"kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/","title":{"rendered":"Kimyrsa: Soluci\u00f3n antibi\u00f3tica para infecciones cut\u00e1neas resistentes"},"content":{"rendered":"<p>Kimyrsa, tambi\u00e9n conocido por su nombre gen\u00e9rico, oritavancina, es un antibi\u00f3tico potente de acci\u00f3n prolongada que se prescribe habitualmente para el tratamiento de infecciones bacterianas de la piel en adultos. Este medicamento antibacteriano se clasifica como un antibi\u00f3tico glucopept\u00eddico. Es eficaz contra bacterias grampositivas, incluyendo <em>Staphylococcus aureus resistente a la meticilina (SARM), Streptococcus pyogenes y Enterococcus faecalis<\/em>.<\/p>\n\n\n\n<div  id=\"call-to-action-73ccf1d7fc3114e8168c74f914266a65\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista \t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>Kimyrsa fue aprobado inicialmente por la Administraci\u00f3n de Alimentos y Medicamentos de EE. UU. en agosto de 2014 para el tratamiento de infecciones bacterianas de la piel. Se administra mediante una \u00fanica infusi\u00f3n intravenosa de una hora. Esto reduce la necesidad de largas hospitalizaciones o dosis repetidas en comparaci\u00f3n con otros antibi\u00f3ticos, como la vancomicina.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#Key_Modes_of_Action\" >Modos de acci\u00f3n clave<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#1_Blocking_Cell_Wall_Synthesis\" >1. Bloqueo de la s\u00edntesis de la pared celular<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#2_Disturbing_Bacterial_Membrane_Integrity\" >2. Alteraci\u00f3n de la integridad de la membrana bacteriana<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#3_Inhibiting_Key_Steps_in_Cell_Wall_Synthesis\" >3. Inhibici\u00f3n de pasos clave en la s\u00edntesis de la pared celular<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#Indication_and_Usage\" >Indicaci\u00f3n y uso<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#Dosage_and_Administration_of_Kimyrsa\" >Dosis y administraci\u00f3n de Kimyrsa<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#Preparation_of_Kimyrsa_for_Intravenous_Infusion\" >Preparaci\u00f3n de Kimyrsa para infusi\u00f3n intravenosa<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#Reported_Adverse_Effects_Side_Effects\" >Efectos adversos notificados (efectos secundarios)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#Common_Side_Effects\" >Efectos secundarios comunes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#Serious_Side_Effects\" >Efectos secundarios graves<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#Kimyrsa_Contraindications\" >Contraindicaciones de Kimyrsa<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#Precautions\" >Precauciones<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#Drug_Interactions\" >Interacciones farmacol\u00f3gicas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#Kimyrsa_Cost\" >Costo de Kimyrsa<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#Kimyrsa_Benefits\" >Beneficios de Kimyrsa<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-key-modes-of-action\"><span class=\"ez-toc-section\" id=\"Key_Modes_of_Action\"><\/span><strong>Modos de acci\u00f3n clave<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Las bacterias tienen una capa protectora llamada pared celular, que funciona como una armadura resistente que las protege y les permite sobrevivir en entornos hostiles (es decir, estr\u00e9s, calor o antibi\u00f3ticos).<\/p>\n\n\n\n<p>Kimyrsa pertenece a la clase de antibi\u00f3ticos lipoglicop\u00e9ptidos. Posee una r\u00e1pida actividad bactericida (eliminaci\u00f3n de bacterias) y act\u00faa atacando la pared celular bacteriana. Esta pared celular es necesaria para el crecimiento y la supervivencia bacteriana. Las infusiones de Kimyrsa combaten las bacterias mediante <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8982769\/\" target=\"_blank\" rel=\"noreferrer noopener\">tres mecanismos de acci\u00f3n bactericidas<\/a>:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-1-blocking-cell-wall-synthesis\"><span class=\"ez-toc-section\" id=\"1_Blocking_Cell_Wall_Synthesis\"><\/span>1. <strong>Bloqueo de la s\u00edntesis de la pared celular<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Kimyrsa impide que las bacterias puedan construir una pared celular a su alrededor.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-2-disturbing-bacterial-membrane-integrity\"><span class=\"ez-toc-section\" id=\"2_Disturbing_Bacterial_Membrane_Integrity\"><\/span>2. <strong>Alteraci\u00f3n de la integridad de la membrana bacteriana<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Kimyrsa altera la integridad de la membrana bacteriana al crear peque\u00f1os agujeros en la pared celular, lo que provoca despolarizaci\u00f3n, permeabilizaci\u00f3n y muerte celular r\u00e1pida.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-inhibiting-key-steps-in-cell-wall-synthesis\"><span class=\"ez-toc-section\" id=\"3_Inhibiting_Key_Steps_in_Cell_Wall_Synthesis\"><\/span>3. <strong>Inhibici\u00f3n de pasos clave en la s\u00edntesis de la pared celular<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Kimyrsa bloquea pasos clave (es decir, transglicosilaci\u00f3n y transpeptidaci\u00f3n) en el proceso de s\u00edntesis de la pared celular, lo que dificulta la supervivencia de las bacterias resistentes (bacterias que son dif\u00edciles de tratar y tienen opciones de tratamiento limitadas).<\/p>\n\n\n\n<p>A trav\u00e9s de estos tres mecanismos de acci\u00f3n, Kimyrsa y otros antibi\u00f3ticos glicopept\u00eddicos pueden atacar ciertas bacterias grampositivas resistentes que pueden causar infecciones cut\u00e1neas graves y complicadas, como Staphylococcus aureus resistente a la meticilina (SARM), especies de Enterococcus resistentes a la vancomicina (REV) y otras.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-indication-and-usage\"><span class=\"ez-toc-section\" id=\"Indication_and_Usage\"><\/span><strong>Indicaci\u00f3n y uso<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Las infusiones de Kimyrsa est\u00e1n aprobadas para el tratamiento de adultos con infecciones bacterianas agudas de la piel y de las estructuras cut\u00e1neas (ABSSSI). La ABSSSI incluye <a href=\"https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/cellulitis\" target=\"_blank\" rel=\"noreferrer noopener\">celulitis<\/a> (infecci\u00f3n grave en la capa m\u00e1s profunda de la piel), <a href=\"https:\/\/medlineplus.gov\/ency\/article\/000863.htm\" target=\"_blank\" rel=\"noreferrer noopener\">abscesos cut\u00e1neos<\/a> (acumulaci\u00f3n de pus dentro de la superficie de la piel) e infecciones de heridas.<\/p>\n\n\n\n<p>Se sospecha que estas infecciones son causadas por bacterias grampositivas resistentes a los antimicrobianos, incluidas SARM y <em>Staphylococcus aureus, Streptococcus pyogenes y Enterococcus faecalis<\/em>.<\/p>\n\n\n\n<p>Kimyrsa se recomienda \u00fanicamente para el tratamiento o la prevenci\u00f3n de infecciones con una fuerte sospecha de ser causadas por bacterias. Esto ayuda a prevenir el desarrollo de bacterias resistentes a los medicamentos y mantiene la eficacia de Kimyrsa y otros antibi\u00f3ticos.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-dosage-and-administration-of-kimyrsa\"><span class=\"ez-toc-section\" id=\"Dosage_and_Administration_of_Kimyrsa\"><\/span><strong>Dosis y administraci\u00f3n de Kimyrsa<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Kimyrsa est\u00e1 disponible en un vial de dosis \u00fanica que contiene 1200 mg de polvo liofilizado de oritavancina.<\/p>\n\n\n\n<p>La dosis recomendada de Kimyrsa para pacientes adultos es de 1200 mg, que se administra lentamente en la vena (infusi\u00f3n intravenosa) por un profesional de la salud durante 1 hora.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-preparation-of-kimyrsa-for-intravenous-infusion\"><span class=\"ez-toc-section\" id=\"Preparation_of_Kimyrsa_for_Intravenous_Infusion\"><\/span><strong>Preparaci\u00f3n de Kimyrsa para infusi\u00f3n intravenosa<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Antes de administrarse, la forma en polvo de Kimyrsa debe reconstituirse con 40 ml de agua est\u00e9ril.<\/li>\n\n\n\n<li>Diluya a\u00fan m\u00e1s la soluci\u00f3n reconstituida extrayendo primero 40 ml de una bolsa de diluyente intravenoso de 250 ml de dextrosa 5% en agua (D5W) o cloruro de sodio 0,9% y luego inyecte los 40 ml de Kimyrsa en la bolsa de diluyente intravenoso, para un volumen total de 250 ml.<\/li>\n\n\n\n<li>Kimyrsa no debe infundirse con ning\u00fan otro medicamento en la misma v\u00eda intravenosa.<\/li>\n\n\n\n<li>Las bolsas de infusi\u00f3n que contienen soluci\u00f3n intravenosa diluida deben usarse dentro de las 4 horas si se almacenan a temperatura ambiente o dentro de las 12 horas si se refrigeran entre 2\u00b0 y 8\u00b0C (36\u00b0 y 46\u00b0F).<\/li>\n<\/ol>\n\n\n\n<div  id=\"call-to-action-76767260142a81c10adb8606b9717b30\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia financiera\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-reported-adverse-effects-side-effects\"><span class=\"ez-toc-section\" id=\"Reported_Adverse_Effects_Side_Effects\"><\/span><strong>Efectos adversos notificados (efectos secundarios)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/12\/kimyrsa-woman-arm-itching.jpg\" alt=\"kimyrsa-woman-arm-itching\" class=\"wp-image-27388\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/12\/kimyrsa-woman-arm-itching.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/12\/kimyrsa-woman-arm-itching-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/12\/kimyrsa-woman-arm-itching-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/12\/kimyrsa-woman-arm-itching-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/12\/kimyrsa-woman-arm-itching-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/12\/kimyrsa-woman-arm-itching-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/12\/kimyrsa-woman-arm-itching-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>Kimyrsa y otros antibi\u00f3ticos glicopept\u00eddicos generalmente son bien tolerados, pero a\u00fan as\u00ed pueden causar efectos secundarios que debes tener en cuenta antes de tomarlos.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-common-side-effects\"><span class=\"ez-toc-section\" id=\"Common_Side_Effects\"><\/span><strong>Efectos secundarios comunes<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Los efectos secundarios m\u00e1s comunes informados por \u22653% de los pacientes despu\u00e9s de recibir infusiones de Kimyrsa fueron dolores de cabeza, n\u00e1useas, v\u00f3mitos, abscesos en las extremidades, taquicardia (frecuencia card\u00edaca r\u00e1pida), abscesos subcut\u00e1neos y diarrea.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-serious-side-effects\"><span class=\"ez-toc-section\" id=\"Serious_Side_Effects\"><\/span><strong>Efectos secundarios graves<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Las reacciones adversas que ocurrieron en \u22652 pacientes despu\u00e9s de tomar Kimyrsa fueron hipersensibilidad (anafilaxia), prurito (picaz\u00f3n), escalofr\u00edos, diarrea intensa (heces acuosas o con sangre), dolor de est\u00f3mago y pirexia (fiebre).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-kimyrsa-contraindications\"><span class=\"ez-toc-section\" id=\"Kimyrsa_Contraindications\"><\/span><strong>Contraindicaciones de Kimyrsa<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Los pacientes con hipersensibilidad conocida no deben tomar productos con oritavancina. Adem\u00e1s, no debe administrarse heparina s\u00f3dica no fraccionada intravenosa, un anticoagulante (diluyente de la sangre), durante 5 d\u00edas (120 horas) despu\u00e9s de tomar oritavancina. Esto se debe a que la oritavancina puede provocar que la prueba del tiempo de tromboplastina parcial activada (TTPa), que mide la coagulaci\u00f3n sangu\u00ednea, muestre resultados falsamente altos hasta por 5 d\u00edas.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-precautions\"><span class=\"ez-toc-section\" id=\"Precautions\"><\/span><strong>Precauciones<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Antes de recibir un tratamiento con antibi\u00f3ticos Kimyrsa, informe a su proveedor de atenci\u00f3n m\u00e9dica si:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Est\u00e1 embarazada o tiene intenci\u00f3n de quedar embarazada<\/li>\n\n\n\n<li>Est\u00e1 amamantando o planea amamantar<\/li>\n\n\n\n<li>Es al\u00e9rgico a la oritavancina.<\/li>\n\n\n\n<li>Est\u00e1n recibiendo inyecciones de heparina<\/li>\n\n\n\n<li>\u00bfEst\u00e1 tomando alg\u00fan medicamento recetado, medicamentos de venta libre, vitaminas, productos a base de hierbas o suplementos nutricionales?<\/li>\n\n\n\n<li>Tiene enfermedad hep\u00e1tica preexistente o trastornos de la coagulaci\u00f3n (problemas de sangrado)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-drug-interactions\"><span class=\"ez-toc-section\" id=\"Drug_Interactions\"><\/span><strong>Interacciones farmacol\u00f3gicas<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Kimyrsa puede interactuar con otros medicamentos, lo que puede reducir su eficacia o aumentar el riesgo de efectos secundarios. Por ejemplo, no se deben tomar anticoagulantes como la heparina o la warfarina junto con Kimyrsa, ya que pueden interferir con las pruebas de coagulaci\u00f3n.<\/p>\n\n\n\n<p>De manera similar, Kimyrsa tampoco debe mezclarse ni administrarse junto con otros antibi\u00f3ticos en la misma l\u00ednea intravenosa debido a una posible incompatibilidad.<\/p>\n\n\n\n<p>Consulte con su proveedor de atenci\u00f3n m\u00e9dica si est\u00e1 tomando alguno de estos medicamentos.<\/p>\n\n\n\n<div  id=\"call-to-action-be675840ad30249a8eb020b21352b943\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia con el copago ahora\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-kimyrsa-cost\"><span class=\"ez-toc-section\" id=\"Kimyrsa_Cost\"><\/span><strong>Costo de Kimyrsa<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Las infusiones de Kimyrsa son un tratamiento costoso, y su alto precio puede ser un obst\u00e1culo para los pacientes sin seguro m\u00e9dico. El costo aproximado de una dosis \u00fanica de 1200 mg de Kimyrsa, disponible como polvo intravenoso para inyecci\u00f3n, ronda los 1447-5629 d\u00f3lares, aunque los precios pueden variar seg\u00fan la farmacia.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-kimyrsa-benefits\"><span class=\"ez-toc-section\" id=\"Kimyrsa_Benefits\"><\/span><strong>Beneficios de Kimyrsa<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Kimyrsa es un antibi\u00f3tico que ejerce un efecto duradero en los pacientes. Est\u00e1 dise\u00f1ado para funcionar con una sola dosis, ya que permanece activo en el organismo durante un tiempo prolongado, aproximadamente 16 d\u00edas. Kimyrsa se elimina lentamente del organismo y, como resultado, contin\u00faa combatiendo las bacterias durante muchos d\u00edas despu\u00e9s de su administraci\u00f3n. Esta caracter\u00edstica de Kimyrsa reduce la necesidad de m\u00faltiples dosis, lo que permite tratar la infecci\u00f3n eficazmente sin requerir una hospitalizaci\u00f3n prolongada.<\/p>","protected":false},"excerpt":{"rendered":"<p>Kimyrsa, tambi\u00e9n conocido por su nombre gen\u00e9rico, oritavancina, es un antibi\u00f3tico potente de acci\u00f3n prolongada que se prescribe habitualmente para el tratamiento de infecciones bacterianas de la piel en adultos. Este medicamento antibacteriano se clasifica como un antibi\u00f3tico glucopept\u00eddico.<\/p>","protected":false},"author":26,"featured_media":27235,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[4],"tags":[32],"class_list":["post-27236","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-other-health-conditions","tag-dr-robert-hakim"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kimyrsa: Antibiotic Solution for Resistant Skin Infections<\/title>\n<meta name=\"description\" content=\"Kimyrsa delivers a single-dose antibiotic solution for stubborn skin infections like MRSA. Learn about its effectiveness, dosing, and potential side effects.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kimyrsa: Antibiotic Solution for Resistant Skin Infections\" \/>\n<meta property=\"og:description\" content=\"Kimyrsa delivers a single-dose antibiotic solution for stubborn skin infections like MRSA. Learn about its effectiveness, dosing, and potential side effects.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-03T19:34:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-28T21:10:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Robert Hakim, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Robert Hakim, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\\\/\"},\"author\":{\"name\":\"Dr. Robert Hakim, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/234280933b6e0dcaf47c0c1f40a59759\"},\"headline\":\"Kimyrsa: Antibiotic Solution for Resistant Skin Infections\",\"datePublished\":\"2024-12-03T19:34:52+00:00\",\"dateModified\":\"2025-04-28T21:10:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\\\/\"},\"wordCount\":961,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/kimyrsa-doctor-patient-arm.jpg\",\"keywords\":[\"Dr. Robert Hakim\"],\"articleSection\":[\"Other Health Conditions\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\\\/\",\"name\":\"Kimyrsa: Antibiotic Solution for Resistant Skin Infections\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/kimyrsa-doctor-patient-arm.jpg\",\"datePublished\":\"2024-12-03T19:34:52+00:00\",\"dateModified\":\"2025-04-28T21:10:02+00:00\",\"description\":\"Kimyrsa delivers a single-dose antibiotic solution for stubborn skin infections like MRSA. Learn about its effectiveness, dosing, and potential side effects.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/kimyrsa-doctor-patient-arm.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/kimyrsa-doctor-patient-arm.jpg\",\"width\":1280,\"height\":853,\"caption\":\"A doctor examining an elderly woman's arm in a medical setting\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kimyrsa: Antibiotic Solution for Resistant Skin Infections\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/234280933b6e0dcaf47c0c1f40a59759\",\"name\":\"Dr. Robert Hakim, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"caption\":\"Dr. Robert Hakim, PharmD\"},\"description\":\"Dr. Robert Chad Hakim, PharmD, was born and raised in Northridge, CA. He received his pharmacy degree from the University of Wisconsin-Madison School of Pharmacy. The most rewarding part of his job is taking initiative to advance clinical programs that maximize impact on patient care. He has a board certification in critical care (BCCCP), and his areas of expertise are critical care, drug information, general medicine, and cardiology. In his free time, he enjoys traveling.\u00a0\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/robert-hakim\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kimyrsa: Soluci\u00f3n antibi\u00f3tica para infecciones cut\u00e1neas resistentes","description":"Kimyrsa ofrece una soluci\u00f3n antibi\u00f3tica de dosis \u00fanica para infecciones cut\u00e1neas persistentes como el SARM. Inf\u00f3rmese sobre su eficacia, dosis y posibles efectos secundarios.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/","og_locale":"es_MX","og_type":"article","og_title":"Kimyrsa: Antibiotic Solution for Resistant Skin Infections","og_description":"Kimyrsa delivers a single-dose antibiotic solution for stubborn skin infections like MRSA. Learn about its effectiveness, dosing, and potential side effects.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2024-12-03T19:34:52+00:00","article_modified_time":"2025-04-28T21:10:02+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg","type":"image\/jpeg"}],"author":"Dr. Robert Hakim, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Robert Hakim, PharmD","Est. reading time":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/"},"author":{"name":"Dr. Robert Hakim, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/234280933b6e0dcaf47c0c1f40a59759"},"headline":"Kimyrsa: Antibiotic Solution for Resistant Skin Infections","datePublished":"2024-12-03T19:34:52+00:00","dateModified":"2025-04-28T21:10:02+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/"},"wordCount":961,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg","keywords":["Dr. Robert Hakim"],"articleSection":["Other Health Conditions"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/","url":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/","name":"Kimyrsa: Soluci\u00f3n antibi\u00f3tica para infecciones cut\u00e1neas resistentes","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg","datePublished":"2024-12-03T19:34:52+00:00","dateModified":"2025-04-28T21:10:02+00:00","description":"Kimyrsa ofrece una soluci\u00f3n antibi\u00f3tica de dosis \u00fanica para infecciones cut\u00e1neas persistentes como el SARM. Inf\u00f3rmese sobre su eficacia, dosis y posibles efectos secundarios.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg","width":1280,"height":853,"caption":"A doctor examining an elderly woman's arm in a medical setting"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/kimyrsa-a-single-dose-antibiotic-for-resistant-skin-infections\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/es\/"},{"@type":"ListItem","position":2,"name":"Kimyrsa: Antibiotic Solution for Resistant Skin Infections"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/234280933b6e0dcaf47c0c1f40a59759","name":"Dr. Robert Hakim, Doctor en Farmacia","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","caption":"Dr. Robert Hakim, PharmD"},"description":"El Dr. Robert Chad Hakim, PharmD, naci\u00f3 y creci\u00f3 en Northridge, California. Obtuvo su t\u00edtulo en farmacia en la Facultad de Farmacia de la Universidad de Wisconsin-Madison. Lo m\u00e1s gratificante de su trabajo es tomar la iniciativa para impulsar programas cl\u00ednicos que maximicen el impacto en la atenci\u00f3n al paciente. Cuenta con una certificaci\u00f3n del consejo en cuidados cr\u00edticos (BCCCP) y sus \u00e1reas de especializaci\u00f3n son cuidados cr\u00edticos, informaci\u00f3n sobre medicamentos, medicina general y cardiolog\u00eda. En su tiempo libre, disfruta viajando.\u00a0","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Robert Hakim, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"},"uagb_comment_info":0,"uagb_excerpt":"Kimyrsa, also known by its generic name, oritavancin, is a potent, long-acting antibiotic typically prescribed for the treatment of bacterial skin infections in adults. This antibacterial medication is classified as a glycopeptide antibiotic.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/04\/kimyrsa-doctor-patient-arm.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Robert Hakim, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/other-health-conditions\/\" rel=\"category tag\">Other Health Conditions<\/a>","rttpg_excerpt":"Kimyrsa, also known by its generic name, oritavancin, is a potent, long-acting antibiotic typically prescribed for the treatment of bacterial skin infections in adults. This antibacterial medication is classified as a glycopeptide antibiotic.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27236","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=27236"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27236\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/27235"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=27236"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=27236"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=27236"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}